kathimerini.gr

New Treatments Show Promise in Reducing High Lipoprotein(a) Levels and Cardiovascular Risk

Research reveals that high lipoprotein(a) [Lp(a)] levels significantly increase cardiovascular risk, but new treatments showing promise could offer effective reductions of up to 80%, potentially impacting 20% of the population with elevated Lp(a).

Read original article in Greek

Greek

Greece

HealthScienceCardiovascular DiseaseHeart HealthCholesterolLp(A)Pcsk9 Inhibitors

Harvard Medical School

Donna Polk

What are the key factors determining Lp(a) levels and how do they influence individual risk assessment and management strategies?: Lp(a), similar to LDL cholesterol but with an additional protein, promotes arterial damage, blood clot formation, and inflammation. Genetic factors primarily determine Lp(a) levels, remaining relatively stable throughout life and unaffected by diet or exercise. Approximately 20% of people have Lp(a) levels that increase their risk of cardiovascular disease.
What are the future implications of ongoing research into Lp(a)-lowering therapies for preventing and treating cardiovascular disease?: Future implications include new drugs targeting Lp(a) production, potentially offering effective treatments for high Lp(a) levels. While statins and lifestyle changes are currently recommended for those at risk, further research is needed to optimize treatment strategies and improve cardiovascular health outcomes. The development of effective Lp(a)-lowering therapies could significantly reduce cardiovascular disease risk in a substantial portion of the population.
What are the latest findings regarding the impact of lipoprotein(a) [Lp(a)] on cardiovascular health and the potential for effective treatments?: High levels of lipoprotein(a) [Lp(a)] in the blood increase cardiovascular risk. While treatments were limited, recent research shows that PCSK9 inhibitors can lower Lp(a) by up to 25%, and even moderate reductions significantly decrease the risk of heart attacks and other serious heart problems. Studies are underway testing new drugs that could reduce Lp(a) by up to 80%.

Cognitive Concepts

1/5

Framing Bias

The framing is generally neutral, presenting information about Lp(a) and its significance in cardiovascular disease. The inclusion of a cardiologist's perspective lends credibility but might subtly emphasize the medical viewpoint over other perspectives. The headline (if any) would significantly influence the framing.

1/5

Language Bias

The language used is largely neutral and informative. There is some use of terms like "bad twin sister" which might be considered slightly sensationalist but it's used to create an analogy that aids understanding. Overall, the language is clear and avoids strong emotional tones.

3/5

Bias by Omission

The article focuses primarily on Lp(a) and its connection to cardiovascular disease, but it omits discussion of other potential risk factors and preventative measures beyond diet, exercise, and statins. While acknowledging genetic predisposition, it doesn't explore the interaction of Lp(a) with lifestyle factors in detail. The omission of alternative treatments or research directions could limit the reader's understanding of the broader landscape of cardiovascular health.

Sustainable Development Goals

Good Health and Well-being Positive

Direct Relevance

The article discusses new developments in understanding and treating Lp(a), a lipoprotein linked to cardiovascular disease. The research and development of new drugs to lower Lp(a) levels directly contribute to improved cardiovascular health and reduced risk of heart attacks and other heart problems, thus positively impacting SDG 3 (Good Health and Well-being). The mention of preventative measures like diet and exercise further supports this.

Jan 29, 04:10

Personalized Cell Products Show Promise in Regenerating Damaged Tissues

Sechenov University scientists are developing personalized biomedicinal cell products (BMCPs) for regenerating vocal cords, eardrums, and nasal cavities; these "cocktails" of a patient's cells and medication promote faster, scar-free healing, with initial success shown in eardrum regeneration in animal studies.

Jan 29, 07:07

New Blood Test Trials Aim to Revolutionize Dementia Diagnosis in the UK

NHS clinics in the UK are conducting trials on a new blood test designed to detect early signs of dementia, addressing the current low diagnosis rate (2%) due to limited access to specialized brain scanners and trained staff; the study involves more than 3,000 patients.

Jan 28, 16:14

Rising Colon Cancer Rates in Young Adults Linked to Lifestyle Changes

Cancer diagnoses are rising among people under 50, with colon cancer showing a particularly sharp increase, linked to lifestyle changes since the 1950s including increased consumption of processed foods, less physical activity, and higher rates of obesity, impacting cellular processes and hormone regulation, while prevention strategies focus on healthier diets and lifestyles.

Jan 28, 13:10

Chronic Stress: An Evolutionary Superpower Turned Modern Health Risk

Chronic stress, a deeply rooted evolutionary response, is causing significant health problems in modern society due to prolonged activation from technology and work, leading to conditions such as high blood pressure, high cholesterol, and obesity; however, mindfulness and exercise offer complementary approaches to manage and build resilience.